In this study, using a transient focal cerebral ischemia mouse model, we hypothesized that BRD4 degrader dBET1 elicits robust neuroprotective efficacy against stroke damage by mechanisms involving regulating inflammatory and oxidative processes along with preserving BBB integrity. Here, BRD4 is linked to stroke disorder.